SCHEMBL8916995

SCHEMBL8916995

COC(=O)Cc1ccc(C(F)(F)F)cc1C(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.46
MAPT P10636 4/20 0.41
KDM4E B2RXH2 2/20 0.41
CES2 O00748 2/20 0.41
CYP2C19 P33261 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
USP2 O75604 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PPARG P37231 1/20 0.40
PPARD Q03181 1/20 0.40
PPARA Q07869 1/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SORT1 Q99523 2/20 0.39
LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29331520 0.83 RXRA (0.51) CFTRMAPTKDM4ECYP2C19ALDH1A1
SCHEMBL7474672 0.83 RXRA (0.51) MAPTKDM4ECES2CYP2C19ALDH1A1
SCHEMBL18075562 0.82 IDO1 (0.50) CFTRMAPTKDM4EALDH1A1HPGD
SCHEMBL27757329 0.82 ANO1 (0.49) CFTRMAPTKDM4EALDH1A1HPGD
SCHEMBL7472612 0.82 CES2 (0.44) CFTRMAPTKDM4ECES2CYP2C19
SCHEMBL15524663 0.81 CFTR (0.43) CFTRMAPTKDM4ECYP2C19ALDH1A1
SCHEMBL835012 0.81 MAPT (0.51) CFTRMAPTKDM4ECYP2C19ALDH1A1
SCHEMBL14453690 0.81 CFTR (0.57) CFTRMAPTKDM4ECYP2C19ALDH1A1
SCHEMBL996522 0.80 CYP1A2 (0.58) CFTRMAPTKDM4ECYP2C19ALDH1A1
SCHEMBL2858243 0.79 CES2 (0.47) CFTRMAPTKDM4ECES2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5670525-A Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the treatment of CNS disorders BAYER AKTIENGESELLSCHAFT (DE) 1997-09-23 US disclosed